Form4.ai tracks every SEC insider trade in real time. See every VRXA insider filing with a free account — no card.
See every VRXA insider filing — free account, no card.
Free accountVeraxa Biotech AG - Post de-SPAC (VRXA) has 5 SEC Form 4 insider filings on record in the last 90 days. That includes 5 insider purchases totalling $135K. Most recent filing: Oct. 29, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 29, 2026 SEC filing | Gruninger Marc Director | Bought | $9,983 | -4.8% 7D |
| Oct 21, 2026 SEC filing | Ziegler Christoph Samuel Director | Bought | $32,700 | -8.3% 7D |
| Sep 29, 2026 SEC filing | Hosseinion Warren Director | Bought | $10,060 | -24.6% 30D |
Create a free account to see all 5 VRXA filings from the last 90 days. No card needed.
Create free accountWant VRXA insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.